Related references
Note: Only part of the references are listed.Genetic characterization of ABT-199 sensitivity in human AML
Richard Bisaillon et al.
LEUKEMIA (2020)
In vivo efficacy of mutant IDH1 inhibitor HMS-101 and structural resolution of distinct binding site
Anuhar Chaturvedi et al.
LEUKEMIA (2020)
Ivosidenib induces deep durable remissions in patients with newly diagnosed IDH1-mutant acute myeloid leukemia
Gail J. Roboz et al.
BLOOD (2020)
Molecular mechanisms mediating relapse following ivosidenib monotherapy in IDH1-mutant relapsed or refractory AML
Sung Choe et al.
BLOOD ADVANCES (2020)
Persistent IDH1/2 mutations in remission can predict relapse in patients with acute myeloid leukemia
Chi Young Ok et al.
HAEMATOLOGICA (2019)
Downregulating Notch counteracts KrasG12D-induced ERK activation and oxidative phosphorylation in myeloproliferative neoplasm
Guangyao Kong et al.
LEUKEMIA (2019)
Vulnerabilities in mIDH2 AML confer sensitivity to APL-like targeted combination therapy
Vera Mugoni et al.
CELL RESEARCH (2019)
Enasidenib, an inhibitor of mutant IDH2 proteins, induces durable remissions in older patients with newly diagnosed acute myeloid leukemia
Daniel A. Pollyea et al.
LEUKEMIA (2019)
Mubritinib Targets the Electron Transport Chain Complex I and Reveals the Landscape of OXPHOS Dependency in Acute Myeloid Leukemia
Irene Baccelli et al.
CANCER CELL (2019)
Inhibition of mitochondrial translation overcomes venetoclax resistance in AML through activation of the integrated stress response
David Sharon et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Molecular remission and response patterns in patients with mutant-IDH2 acute myeloid leukemia treated with enasidenib
Eytan M. Stein et al.
BLOOD (2019)
Large-Scale Modeling Approach Reveals Functional Metabolic Shifts during Hepatic Differentiation
Nathalie Poupin et al.
JOURNAL OF PROTEOME RESEARCH (2019)
Mutant-IDH1-dependent chromatin state reprogramming, reversibility, and persistence
Sevin Turcan et al.
NATURE GENETICS (2018)
Glutaminolysis is a metabolic dependency in FLT3ITD acute myeloid leukemia unmasked by FLT3 tyrosine kinase inhibition
Paolo Gallipoli et al.
BLOOD (2018)
Glutaminase inhibition improves FLT3 inhibitor therapy for acute myeloid leukemia
Mark A. Gregory et al.
EXPERIMENTAL HEMATOLOGY (2018)
An inhibitor of oxidative phosphorylation exploits cancer vulnerability
Jennifer R. Molina et al.
NATURE MEDICINE (2018)
Clonal heterogeneity of acute myeloid leukemia treated with the IDH2 inhibitor enasidenib
Lynn Quek et al.
NATURE MEDICINE (2018)
Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML
C. D. DiNardo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Oncogenic IDH1 Mutations Promote Enhanced Proline Synthesis through PYCR1 to Support the Maintenance of Mitochondrial Redox Homeostasis
Kate E. R. Hollinshead et al.
CELL REPORTS (2018)
Consumption of NADPH for 2-HG Synthesis Increases Pentose Phosphate Pathway Flux and Sensitizes Cells to Oxidative Stress
Susan J. Gelman et al.
CELL REPORTS (2018)
Acquired resistance to IDH inhibition through trans or cis dimer-interface mutations
Andrew M. Intlekofer et al.
NATURE (2018)
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade
Livnat Jerby-Arnon et al.
CELL (2018)
Functional genomic landscape of acute myeloid leukaemia
Jeffrey W. Tyner et al.
NATURE (2018)
Loss of epigenetic regulator TET2 and oncogenic KIT regulate myeloid cell transformation via PI3K pathway
Lakshmi Reddy Palam et al.
JCI INSIGHT (2018)
MetExploreViz: web component for interactive metabolic network visualization
Maxime Chazalviel et al.
BIOINFORMATICS (2018)
Pan-mutant-IDH1 inhibitor BAY1436032 is highly effective against human IDH1 mutant acute myeloid leukemia in vivo
A. Chaturvedi et al.
LEUKEMIA (2017)
The creatine kinase pathway is a metabolic vulnerability in EVI1-positive acute myeloid leukemia
Nina Fenouille et al.
NATURE MEDICINE (2017)
Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism
Thomas Farge et al.
CANCER DISCOVERY (2017)
AG-221, a First-in-Class Therapy Targeting Acute Myeloid Leukemia Harboring Oncogenic IDH2 Mutations
Katharine Yen et al.
CANCER DISCOVERY (2017)
Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles (vol 18, pg 2780, 2017)
Farshad Farshidfar et al.
CELL REPORTS (2017)
IDH1 Mutation Promotes Tumorigenesis by Inhibiting JNK Activation and Apoptosis Induced by Serum Starvation
Bin Jiang et al.
CELL REPORTS (2017)
Enasidenib induces acute myeloid leukemia cell differentiation to promote clinical response
Michael D. Amatangelo et al.
BLOOD (2017)
Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia
Eytan M. Stein et al.
BLOOD (2017)
IDH Mutation, Competitive Inhibition of FTO, and RNA Methylation
Sara M. Elkashef et al.
CANCER CELL (2017)
Understanding the Intersections between Metabolism and Cancer Biology
Matthew G. Vander Heiden et al.
CELL (2017)
Insulator dysfunction and oncogene activation in IDH mutant gliomas
William A. Flavahan et al.
NATURE (2016)
Mutant IDH1 Downregulates ATM and Alters DNA Repair and Sensitivity to DNA Damage Independent of TET2
Satoshi Inoue et al.
CANCER CELL (2016)
The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction
Nicole E. Scharping et al.
IMMUNITY (2016)
Isocitrate dehydrogenase 1 mutations prime the all-trans retinoic acid myeloid differentiation pathway in acute myeloid leukemia
Helena Boutzen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
Chromatin-Bound MDM2 Regulates Serine Metabolism and Redox Homeostasis Independently of p53
Romain Riscal et al.
MOLECULAR CELL (2016)
Genomic Classification and Prognosis in Acute Myeloid Leukemia
Elli Papaemmanuil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Efficacy and Biological Correlates of Response in a Phase II Study of Venetoclax Monotherapy in Patients with Acute Myelogenous Leukemia
Marina Konopleva et al.
CANCER DISCOVERY (2016)
Inhibiting glutaminase in acute myeloid leukemia: metabolic dependency of selected AML subtypes
Polina Matre et al.
ONCOTARGET (2016)
Extreme Vulnerability of IDH1 Mutant Cancers to NAD plus Depletion
Kensuke Tateishi et al.
CANCER CELL (2015)
An Essential Role of the Mitochondrial Electron Transport Chain in Cell Proliferation Is to Enable Aspartate Synthesis
Kivanc Birsoy et al.
CELL (2015)
Supporting Aspartate Biosynthesis Is an Essential Function of Respiration in Proliferating Cells
Lucas B. Sullivan et al.
CELL (2015)
2-Hydroxyglutarate Inhibits ATP Synthase and mTOR Signaling
Xudong Fu et al.
CELL METABOLISM (2015)
NADP+-IDH Mutations Promote Hypersuccinylation that Impairs Mitochondria Respiration and Induces Apoptosis Resistance
Feng Li et al.
MOLECULAR CELL (2015)
Metabolic pathways promoting cancer cell survival and growth
Lindsey K. Boroughs et al.
NATURE CELL BIOLOGY (2015)
New IDH1 mutant inhibitors for treatment of acute myeloid leukemia
Ujunwa C. Okoye-Okafor et al.
NATURE CHEMICAL BIOLOGY (2015)
Isocitrate dehydrogenase 1 and 2 mutations induce BCL-2 dependence in acute myeloid leukemia
Steven M. Chan et al.
NATURE MEDICINE (2015)
Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype
Elisabet Cuyas et al.
ONCOTARGET (2015)
Tyrosine Kinase Inhibition in Leukemia Induces an Altered Metabolic State Sensitive to Mitochondrial Perturbations
Francesca Alvarez-Calderon et al.
CLINICAL CANCER RESEARCH (2015)
IDH1 Mutations Alter Citric Acid Cycle Metabolism and Increase Dependence on Oxidative Mitochondrial Metabolism
Alexandra R. Grassian et al.
CANCER RESEARCH (2014)
Proto-Oncogenic Role of Mutant IDH2 in Leukemia Initiation and Maintenance
Lev M. Kats et al.
CELL STEM CELL (2014)
Pre-leukemic evolution of hematopoietic stem cells: the importance of early mutations in leukemogenesis
M. R. Corces-Zimmerman et al.
LEUKEMIA (2014)
Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia
Liran I. Shlush et al.
NATURE (2014)
Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function
Andrea Viale et al.
NATURE (2014)
Glioma Cells with the IDH1 Mutation Modulate Metabolic Fractional Flux through Pyruvate Carboxylase
Jose L. Izquierdo-Garcia et al.
PLOS ONE (2014)
Oleic Acid Stimulates Complete Oxidation of Fatty Acids through Protein Kinase A-dependent Activation of SIRT1-PGC1α Complex
Ji-Hong Lim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Mitochondrial energetic and AKT status mediate metabolic effects and apoptosis of metformin in human leukemic cells
S. Scotland et al.
LEUKEMIA (2013)
A community-driven global reconstruction of human metabolism
Ines Thiele et al.
NATURE BIOTECHNOLOGY (2013)
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
Timothy J. Ley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
(R)-2-Hydroxyglutarate Is Sufficient to Promote Leukemogenesis and Its Effects Are Reversible
Julie-Aurore Losman et al.
SCIENCE (2013)
An Inhibitor of Mutant IDH1 Delays Growth and Promotes Differentiation of Glioma Cells
Dan Rohle et al.
SCIENCE (2013)
Targeted Inhibition of Mutant IDH2 in Leukemia Cells Induces Cellular Differentiation
Fang Wang et al.
SCIENCE (2013)
Meta-analysis of IDH-mutant cancers identifies EBF1 as an interaction partner for TET2
Paul Guilhamon et al.
NATURE COMMUNICATIONS (2013)
D-2-hydroxyglutarate produced by mutant IDH1 perturbs collagen maturation and basement membrane function
Masato Sasaki et al.
GENES & DEVELOPMENT (2012)
IDH mutation impairs histone demethylation and results in a block to cell differentiation
Chao Lu et al.
NATURE (2012)
DIANA miRPath v.2.0: investigating the combinatorial effect of microRNAs in pathways
Ioannis S. Vlachos et al.
NUCLEIC ACIDS RESEARCH (2012)
Inhibition of Mitochondrial Translation as a Therapeutic Strategy for Human Acute Myeloid Leukemia
Marko Skrtic et al.
CANCER CELL (2011)
Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent Dioxygenases
Wei Xu et al.
CANCER CELL (2011)
PGC1α Promotes Tumor Growth by Inducing Gene Expression Programs Supporting Lipogenesis
Kavita Bhalla et al.
CANCER RESEARCH (2011)
The cAMP/PKA Pathway Rapidly Activates SIRT1 to Promote Fatty Acid Oxidation Independently of Changes in NAD+
Zachary Gerhart-Hines et al.
MOLECULAR CELL (2011)
iMAT: an integrative metabolic analysis tool
Hadas Zur et al.
BIOINFORMATICS (2010)
Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
Maria E. Figueroa et al.
CANCER CELL (2010)
Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction
Ismael Samudio et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
IDH1 and IDH2 Gene Mutations Identify Novel Molecular Subsets Within De Novo Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study
Guido Marcucci et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Computational reconstruction of tissue-specific metabolic models: application to human liver metabolism
Livnat Jerby et al.
MOLECULAR SYSTEMS BIOLOGY (2010)
Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling
Roel G. W. Verhaak et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Recurring Mutations Found by Sequencing an Acute Myeloid Leukemia Genome
Elaine R. Mardis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
The LKB1-AMPK pathway: metabolism and growth control in tumour suppression
David B. Shackelford et al.
NATURE REVIEWS CANCER (2009)
Akt/PKB regulates hepatic metabolism by directly inhibiting PGC-1α transcription coactivator
Xinghai Li et al.
NATURE (2007)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
A robot-based platform to measure multiple enzyme activities in Arabidopsis using a set of cycling assays:: Comparison of changes of enzyme activities and transcript levels during diurnal cycles and in prolonged darkness
Y Gibon et al.
PLANT CELL (2004)
Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1α interaction
P Puigserver et al.
NATURE (2003)
Share Paper
